Home › Deep Vein Thrombosis › NCT05881798
Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study
Post-Market Celect Platinum Vena Cava Filter and Günther Tulip Retrieval Set Study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * A patient dataset is deemed suitable for inclusion if the patient has a procedure where a Celect Platinum Vena Cava Filter is placed * Subject has not previously participated in the Cook MDR-2126 study. Exclusion Criteria: * Patients will be excluded from enrollment if the patient or his/her legally authorized representative objects to collection and processing of his/her data or is not willing to sign the Informed Consent.
About the study
This prospective, observational, post-market study will be performed to collect patient-level data on the Celect Platinum Vena Cava Filter Sets and the Günther Tulip Vena Cava Filter Retrieval Set to confirm continued safety and performance of the devices throughout their expected lifetime and continued acceptability of the benefit:risk ratio. Additionally, the study intends to evaluate longer-term (i.e., up to 5 years) outcome data while the filter is indwelling.
What is being tested
- Celect Platinum Vena Cava Filter (device)
Sponsor: Cook Research Incorporated · Participants: 82 · Started: Jun 2, 2025
Contact the study team
- Sabina Andersen · Phone: +45 29 73 41 34
Official record on ClinicalTrials.gov — NCT05881798
Locations in the U.S.
| California | Cedars-Sinai Medical Center, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.